Source: Eur Respir J 2004; 23: 797-798



Rating:

Share or cite this content

Citations should be made in the following way:
Shale D.J., Ionescu A.A.. Mucus hypersecretion: a common symptom, a common mechanism?. Eur Respir J 2004; 23: 797-798

Member's Comments

No comment yet.

Related content which might interest you: Mucus hypersecretion in COPD: should we only rely on symptoms? Source: Eur Respir Rev 2009; 19: 94-96 Year: 2010 Mucus hypersecretion in fatal asthma: role of EGFR cascade Source: Eur Respir J 2002; 20: Suppl. 38, 207s Year: 2002 Possible mechanisms of worsening bronchial asthma coexisting with thyroid gland pathology Source: Annual Congress 2013 –Asthma: new mechanisms and markers Year: 2013 Are ²volume responders² more common in patients with irreversible airway obstruction? Source: Eur Respir J 2003; 22: Suppl. 45, 6s Year: 2003 What is ‘mild asthma’, and how common is it? Source: International Congress 2018 – The complexities of managing mild asthma Year: 2018 Cough: physiology and pathophysiology Source: Annual Congress 2005 - Management of airway hypersecretions Year: 2005 An example: Eosinophilic airway inflammation as a treatable trait Source: ERS Research Seminar 2017 – Precision medicine in airway diseases Year: 2017 Mucus and microbes: why does bronchiectasis develop? Source: Virtual Congress 2020 – The future of bronchiectasis management Year: 2020 Bronchiectasis in severe uncontrolled asthma: A common feature Source: Annual Congress 2013 –Phenotyping asthma: clinical severity, comorbid conditions response to treatment? Year: 2013 Chronic mucus hypersecretion in severe asthma Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Severity of bronchial asthma: possible mechanisms Source: Annual Congress 2007 - Towards an understanding of asthma pathogenesis - novel in vitro assays and results from animal models Year: 2007 Revisited role for mucus hypersecretion in the pathogenesis of COPD Source: Eur Respir Rev 2009; 19: 109-112 Year: 2010 Is there a secondary defect in CFTR in the nasal epithelium of patients with primary ciliary dyskinesia? Source: International Congress 2016 – Novel insights into alveolar and bronchial epithelial cell injury and repair Year: 2016 Cough dysfunction: What to measure? When to treat? Source: Annual Congress 2008 - PG19 - Ventilatory management and cough enhancement in patients with neuromuscular disease Year: 2008 Expression of nasal and bronchial IL-17F and related cytokines in frequent exacerbators with neutrophilic severe asthma Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Alveolar macrophages phenotype in patients with asthma and its combination with gastroesophageal reflux disease with pulmonary manifestations Source: International Congress 2015 – Mucosal immunology: what’s new in 2015 Year: 2015 Asthma and diabetes type 2 and their co-existence: Possible changes in lung function and their importance Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 What are the common biological mechanisms that lead to obstructive airway disease? Source: International Congress 2016 – Early life origins of asthma and COPD Year: 2016 Late Breaking Abstract - Overlap of SGRQ and CAT-defined chronic mucus hypersecretion in the SPIROMICS cohort: implications for digital health Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018 Bronchial epithelium is already abnormal in children with severe asthma Source: International Congress 2015 – Paediatric asthma and allergy: asthma management Year: 2015